| ASSET | QUARTER | % RETURN |
|---|---|---|
Berkshire Hathaway (BRK.A) | Q1 2022 | 17.02% |
Berkshire Hathaway (BRK.B) | Q1 2022 | 17.6% |
AbbVie (ABBV) | Q1 2022 | 20.96% |
Exxon Mobil (XOM) | Q1 2022 | 36.36% |
Chevron (CVX) | Q1 2022 | 40.13% |
T-Mobile US (TMUS) | Q2 2022 | 4.32% |
Exxon Mobil (XOM) | Q2 2022 | 5.52% |
International Business Machines (IBM) | Q2 2022 | 10.21% |
Merck (MRK) | Q2 2022 | 11.83% |
Eli Lilly and (LLY) | Q2 2022 | 13.69% |
Morgan Stanley (MS) | Q3 2022 | 5.28% |
Amazon (AMZN) | Q3 2022 | 6.31% |
Walmart (WMT) | Q3 2022 | 6.83% |
Tesla (TSLA) | Q3 2022 | 16.85% |
Netflix (NFLX) | Q3 2022 | 33.4% |
JPMorgan Chase (JPM) | Q4 2022 | 28.1% |
Merck (MRK) | Q4 2022 | 28.79% |
ASML Holding NV ADR (ASML) | Q4 2022 | 29.38% |
Novo Nordisk A-S (NVO) | Q4 2022 | 33.21% |
Oracle (ORCL) | Q4 2022 | 34.7% |
Mega-cap stocks are treated as having a market cap of $200B+.
